Bioimpedance Analyzers Market By Product Type(Multi-Frequency Analyzers, Single-Frequency Analyzers), By Technology(Wired Bioimpedance Analyzers, Wireless Bioimpedance Analyzers), By End User(Fitness Clubs & Wellness Centers, Hospitals, Other End User), and by Region and Companies Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032.

Bioimpedance Analyzers Market Overview:

The Bioimpedance Analyzers Market is projected to reach a valuation of USD 778.43 Mn by 2032 at a CAGR of 10.3%, from USD 432.28 Mn in 2021.

Bioimpedance Analysis (BIA) or Bio-electrical Impedance Analysis is a method of assessing an individual’s body composition, i.e., the measurement of body fat in relation to lean body mass. This non-invasive test involves the placement of two electrodes on an individual’s right hand and foot.

A low-level electrical current is sent through the body. The flow of this current is affected by the amount of water in his/her body. The device measures how this signal is impeded through different types of tissue. As such, Bioimpedance Analysis determines the resistance to flow of the current as it passes through an individual’s body, and also provides estimates of body water from which body fat is calculated using selected equations.

Bioimpedance analysis is an integral part of health as well as nutrition assessments. An optimal balance of body fat is associated with good health. Excess fat may increase risks for cardiovascular disease, diabetes, etc. Bioimpedance analysis allows for the early detection of an improper balance in an individual’s body composition.

BIA also provides a measurement of fluid and body mass that can be a critical assessment tool for one’s current state of health. Bioelectrical impedance methods are typically classified by a number of frequencies utilized for the analysis. Bioimpedance analyzers are available in single as well as multiple frequencies. These analyzers are portable in nature, ease-to-use, and have a relatively low cost. These aforementioned factors are anticipated to bolster revenue growth prospects for the global bioimpedance analyzers market.

Detailed Segmentation:

The global bioimpedance analyzers market is segmented on the basis of – product type, technology, and end-user. A detailed segmental description is listed below:

Based on Product Type

• Multi-Frequency Analyzers
• Single-Frequency Analyzers

Technology

• Wired Bioimpedance Analyzers
• Wireless Bioimpedance Analyzers

End User

• Fitness Clubs & Wellness Centers
• Hospitals
• Other End User

Based on Region

• North America
• Europe
• Asia-Pacific
• South America
• The Middle East and Africa

Market Dynamics

Increasing levels of sedentary work environments, paired with a spike in the consumption of junk food have led to an increase in the prevalence of various diseases, such as obesity, high blood pressure, diabetes, etc.

A bioimpedance analyzer offers an accurate measurement of the amount of fat, muscle, and bone in the human body. This is a crucial factor that is anticipated to bolster the revenue growth of the global bioimpedance analyzers market over the forecast period. In addition, a growing prevalence of lifestyle-related diseases, increasing awareness pertaining to health & obesity, and infrastructural improvements in emerging economies such as China, India, and Brazil are anticipated to augment projected revenues for the global bioimpedance analyzers market.

Inconsistencies in the accuracy of bioimpedance analyzers are likely to restrain potential expansion opportunities for this industry to a certain extent. However, the increasing number of weight loss clinics, fitness clubs, and sports rehabilitation centers are expected to propel the financial development of the global bioimpedance analyzers market in the foreseeable future.

Moreover, consistent growth in the GDP of both developed and developing nations have also aided in the evolution of the healthcare sector. Owing to this aforementioned growth in GDP, particularly in that of emerging countries, prominent market players have exhibited a keen sense of interest in these regions, thereby complementing revenue expansion prospects for the global bioimpedance analyzers market.

Competitive Landscape:

Certain key players operating in this global market are

• Omron Corporation
• Tanita Corporation
• InBody
• RJL Systems
• seca GmbH &Co. KG
• EVOLT 360
• SELVAS Healthcare
• Charder Electronic Co. Ltd.
• Fook Tin Group Holding Ltd.
• Bodystat Ltd.
• Maltron International
• Biotekna
• Withings
• and Biodynamics Corporation
• among others.

These aforementioned companies develop new products/services, adopt expansion strategies, and undertake partnerships, collaborations, and mergers & acquisitions to gain traction in the global bioimpedance analyzers market.

Key Developments:

• In 2020, Inbody launched the ThInBody 970 at CES Las Vegas
• In 2017, Selvas Healthcare launched the ACCUNIQ BC380 artificial intelligence-based body composition analyzer globally.